News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
David Steensma: Fascinating to see combination trials of ruxolitinib+ reading out in myelofibrosis
Photo from David Steensma/X
Dec 1, 2023, 07:34

David Steensma: Fascinating to see combination trials of ruxolitinib+ reading out in myelofibrosis

David Steensma, Chief Medical Officer of Ajax Therapeutics, posted on X/Twitter:

“After so many years of involvement in HMA+ combination trials in MDS, it is fascinating to see combination trials of ruxolitinib+ reading out in myelofibrosis.”

Source: David Steensma/Twitter

cancer David Steensma myelofibrosis OncoDaily Oncology ruxolitinib
Special Coverage
Career
Dec 23, 2024, 06:28
Fadi Haddad: Elise Nassif Haddad received the Rising Star Award for Excellence in Clinical Care
Insight
Dec 23, 2024, 06:21
Drew Moghanaki: The largest randomized phase III trial evaluating lung SBRT
Science
Dec 23, 2024, 06:08
Emanuele Crupi: N4 appears to be far more complex than we initially imagined
Blog
Dec 23, 2024, 06:05
Eric Singhi: Naveen Pemmaraju was named FY24 Fastest PI at MD Anderson DoCM
Blog
Dec 23, 2024, 06:00
Anirban Maitra: Targeting the PI3Ka-RAS interaction axis
Blog
Dec 23, 2024, 05:56
Megan-Claire Chase: The different layers of advocacy, both in the public eye and behind the scenes
Blog
Dec 23, 2024, 05:49
Shikha Jain: From Burnout to Breakthrough - How These Entrepreneurs Are Empowering Women in Healthcare
Blog
Dec 23, 2024, 05:43
Pashtoon Kasi: City of Hope Buys 52 Acres in Orange County for $89M
Blog
Dec 23, 2024, 05:31
The Leukemia Lymphoma Society - Give today for a brighter tomorrow for those affected by Blood Cancer
Blog
Dec 22, 2024, 18:02
Erman Akkus: Negative hyper-selection for anti-EGFR therapy in mCRC
Insight
Dec 22, 2024, 17:57
Gustavo Viani: Internal Mammary Node Radiation, A Survival Boost for Breast Cancer Patients?
Insight
Dec 22, 2024, 17:54
Stephen Liu: The seminal IPASS trial in EGFR NSCLC